Clinical trials
Rectal Prolapse trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 2 |
| 2019 | 4 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Unknown status | 13 |
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mansoura University | 3 |
| Zagazig University | 3 |
| Aarhus University Hospital | 2 |
| Manchester University NHS Foundation Trust | 2 |
| novoGI | 2 |
| Al-Azhar University | 1 |
| Alexander Khitaryan | 1 |
| Assiut University | 1 |
| Azerbaijan Medical University | 1 |
| Azienda Ospedaliera Cardinale G. Panico | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rectal Prolapse | 52 |
| Rectocele | 8 |
| Prolapse | 6 |
| Pelvic Organ Prolapse | 5 |
| Colorectal Neoplasms | 4 |
| Hernia | 4 |
| Colitis, Ulcerative | 3 |
| Colonic Neoplasms | 3 |
| Crohn Disease | 3 |
| Diverticulitis | 3 |
Trials
Showing 26 to 50 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.